Gibson Dunn Advises Assertio Holdings on Sale of the Company and Its U.S. Sales and Distribution Rights for Seven Branded Products

Firm News  |  April 9, 2026

---

Gibson Dunn is advising Assertio Holdings on its sale to Garda Therapeutics. Gibson Dunn also is advising Assertio Holdings on its sale of the U.S. sales and distribution rights for a portfolio of seven branded products to Cosette Pharmaceuticals.

Gibson Dunn regularly advises life sciences companies on complex M&A transactions and divestitures in the pharmaceutical sector.

The Gibson Dunn corporate team includes Ryan Murr, Branden Berns, and Evan D’Amico.